Maria de la Torre
Adult Medicine · Miami, FLNPI 1346507944
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. GSK accounts for 62.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $125 and has fallen 68.0% since, to $40 in 2024. That places this record below the midpoint for adult medicine clinicians in FL, where the typical reported total is $365.
Across 8 payments — averaging $33.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$165
- Johnson & Johnson$42
- Amgen$19
- Merck$19
- Phadia US Inc.$18
Across 37 payments — averaging $18,517 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$651K
- Takeda Pharmaceuticals U.S.A., Inc.$19K
- AbbVie$12K
- Novartis$3K
What the payments were for
- Food & beverage$264100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 3 | $165 |
| Johnson & Johnson | 2 | $42 |
| Amgen | 1 | $19 |
| Merck | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHINGRIX$125
How this compares
$264 in reported general payments places this provider in the 45th percentile of 195 adult medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 348 | $187,582 |
| EliquisApixaban | 179 | $109,476 |
| EntrestoSacubitril/Valsartan | 76 | $56,860 |
| DapagliflozinDapagliflozin Propanediol | 90 | $32,491 |
| OzempicSemaglutide | 31 | $32,131 |
| JardianceEmpagliflozin | 24 | $25,692 |
| MyrbetriqMirabegron | 40 | $20,346 |
| GlyxambiEmpagliflozin/Linagliptin | 11 | $15,989 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 19 | $15,428 |
| AlogliptinAlogliptin Benzoate | 58 | $8,398 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 23 | $8,212 |
| NamzaricMemantine Hcl/Donepezil Hcl | 11 | $6,823 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 35 | $6,724 |
| Fluticasone-VilanterolFluticasone/Vilanterol | 24 | $5,787 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 26 | $4,986 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $42 | $187,582348 claims |
| GSKShingrix | $165 | $6,72435 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 195 adult medicine providers in Florida.
Other adult medicine in Miami
- Steven SantiagoMiami$290K
- Hernando ChongMiami$9K
- Agustin AlfonsoMiami$1K
- Tammy DsouzaKissimmee$191K
- Eric SchertzerPlantation$26K
- Ricardo SerranoMerritt Island$20K
- Marlene JarinMiami Beach$18K
- Myra ReedPanama City Beach$16K
- Joshua RycusCoral Springs$13K
- Frederick WeigandDeltona$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.